IbogaineVault / Portal / Mechanisms

Ibogaine: A Review

Alper, Kenneth R. · 2001 · The Alkaloids: Chemistry and Biology

Mechanisms Review moderate
⚠ Contains fatality data

AI-extracted · unverified · confirm at source

Comprehensive ibogaine pharmacology synthesis: NMDA, opioid, 5-HT, nicotinic interactions. Novel mechanism distinct from existing treatments. 10 μM brain levels validate in vitro activities.

Dosing: 4.5–29 mg/kg oral (oral)

Sample size: 41

Contraindications: Pre-existing cardiac disease, Concomitant opioid use

View entry in vault ↗